FDA Inspection 1118683 — Cdymax (India) Pharma Private Limited
The FDA completed an inspection of Cdymax (India) Pharma Private Limited on January 31, 2020 in Bangalore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 31, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bangalore (India)